Market Place
Sourcing Support
EQT to Acquire Adalvo, a Leading B2B Dossier Developer
19 Jul 2025 //
PR NEWSWIRE
Experts Analyse OBBBA`s impact on Indian pharma industry
17 Jul 2025 //
PHARMABIZ
Novartis boosts FY 2025 core income outlook on robust Q2 sales
17 Jul 2025 //
GLOBENEWSWIRE
India`s Pharma Exports Resilient Amid Global Volatility
17 Jul 2025 //
EXPRESS PHARMA
Lupin launches Loteprednol Etabonate Ophthalmic Suspension in US
17 Jul 2025 //
EXPRESS PHARMA
ET Graphics: Tirzepatide, Semaglutide lead India, misuse concerns
16 Jul 2025 //
ECONOMICTIMES
ViiV expands Licence to Allow generic HIV treatment production
15 Jul 2025 //
REUTERS
Aurobindo to Produce, Supply Long Acting HIV Treatment Drug
15 Jul 2025 //
ECONOMICTIMES
Novartis Loses Bid to Block Us Entresto Generic Through 2026
14 Jul 2025 //
REUTERS
Sun Pharma Settles Litigation with Incyte Corp Over Leqselvi
14 Jul 2025 //
ECONOMICTIMES
Amphastar Aims to Quadruple Domestic Manufacturing Capacity
14 Jul 2025 //
ACCESSWIRE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
10 Jul 2025 //
PRESS RELEASE
Gilead Enlists Global Fund in Access Campaign for New PrEp Med
10 Jul 2025 //
PRESS RELEASE
Panacea Biotec, Apotex Settle Collaboration Agreement Breach
09 Jul 2025 //
ECONOMICTIMES
US Consumers to Bear High Tariff Impact from Domestic Pharma
09 Jul 2025 //
ECONOMICTIMES
J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug
09 Jul 2025 //
REUTERS
Taiho’s DMD asset misses in phase 3 trial
09 Jul 2025 //
PRESS RELEASE
Akash Kedia Warns of Us Pricing Reform Impact on Indian Pharma
07 Jul 2025 //
PHARMABIZ
Dr Raj Nagarkar discusses acute shortages in Indian healthcare
05 Jul 2025 //
PHARMABIZ
Lupin Gets FDA nod for Loteprednol Etabonate Ophthalmic Gel
03 Jul 2025 //
EXPRESSPHARMA
FDA Confirms Para IV Patent Litigation for Veklury Powder for Inj
03 Jul 2025 //
FDA
Pharmexcil Talks with US on Trade Facilitation, Market Access
02 Jul 2025 //
PHARMABIZ
Cadila Pharmaceuticals launches Bilacad Dex Syrup
02 Jul 2025 //
INDPHARMAPOST
Asahi Kasei Pharma Begins Phase III Study on Cipn Prevention
02 Jul 2025 //
EXPRESSPHARMA
Europe Must Restore Generic Manufacturing Autonomy: Teva Exec
01 Jul 2025 //
FIERCE PHARMA
Alembic Gets US FDA Approval for Doxorubicin Liposome
30 Jun 2025 //
EXPRESSPHARMA
Alembic Announces USFDA Final Approval for Single-Dose Vials
29 Jun 2025 //
INDPHARMAPOST
India`s Biocon Drops Plan to Launch Weight-Loss Drugs in China
27 Jun 2025 //
REUTERS
Lupin receives USFDA approval for Prucalopride Tablets
26 Jun 2025 //
INDPHARMAPOST
Lupin Launches Prucalopride Tablets in U.S.
26 Jun 2025 //
EXPRESSPHARMA
Study: Delaying Authorized Generics Is on The Decline
25 Jun 2025 //
RAPS
DHODH Inhibitors Market to Reach New Heights by 2034 in Oncology
25 Jun 2025 //
PR NEWSWIRE
Accord Healthcare Launches Dehydrated Alcohol Injection
25 Jun 2025 //
PR NEWSWIRE
Cigna Files Anti-Competition Lawsuit Against BMS Over Pomalyst
25 Jun 2025 //
FIERCE PHARMA
JB Chemicals Gets USFDA Nod for Amitriptyline Tablets
25 Jun 2025 //
BUSINESS STD
Breckenridge Gets FDA Nod for Dehydrated Alcohol Injection
24 Jun 2025 //
PR NEWSWIRE
Ivermectin Now Available Over-the-Counter in Arkansas - Iverpure
24 Jun 2025 //
ACCESSWIRE
BMJ Finds More Irregularities in Trial Data for Az`s Brilinta
24 Jun 2025 //
FIERCE PHARMA
FDA Finalizes Guidance on Requesting Post-Warning Letter Meetings
23 Jun 2025 //
RAPS
EU regulator backs Conditional Authorisation for Madrigal`s Drug
21 Jun 2025 //
REUTERS
Mallinckrodt Publishes Real-World Insights on Acthar Gel
18 Jun 2025 //
PR NEWSWIRE
Glenmark Launches Olopatadine Eye Drops in US Market
16 Jun 2025 //
PR NEWSWIRE
Medac & Clinigen Expand Asia-Pacific Partnership Patient Care
16 Jun 2025 //
PRESS RELEASE
ASCP and NCPA Announce Joint Recommendations to Manufacturers
13 Jun 2025 //
ACCESSWIRE
AB Science Gets Canada Patent for AB8939 in AML Till 2036
12 Jun 2025 //
GLOBENEWSWIRE
Cadila launches Biscado for Cardiovascular Disease Management
10 Jun 2025 //
EXPRESSPHARMA
Lupin Gets Tentative US FDA Nod for Oxcarbazepine Tablet
09 Jun 2025 //
EXPRESSPHARMA
Mallinckrodt, Endo Plan Leadership Team for Merged Company
09 Jun 2025 //
PR NEWSWIRE
Indian Pharma Faces US Pricing Reform & Europe’s Cost-Effectivene
09 Jun 2025 //
PHARMABIZ
Tevogen Expands HQ Due to AI and Generics Growth
09 Jun 2025 //
GLOBENEWSWIRE
Novartis Asks Court for Swift Decision in Entresto Patent Case
07 Jun 2025 //
FIERCE PHARMA
NRx Pharmaceuticals files ANDA for Preservative-Free IV Ketamine
05 Jun 2025 //
PR NEWSWIRE
Harmony Biosciences Strengthens Patent Position with Settlement
05 Jun 2025 //
BUSINESSWIRE
Gland Pharma receives FDA approval for Angiotensin II Acetate Inj
05 Jun 2025 //
EXPRESSPHARMA
Polpharma Group Backs EU Action to Protect Medicine Access
05 Jun 2025 //
PRESS RELEASE
NPPA Sets Prices for 41 Drug Combos, Including Empagliflozin
04 Jun 2025 //
BUSINESS STD
FDA Confirms Para IV Patent Litigation for Suflave Solution
03 Jun 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Valtoco Spray
03 Jun 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Qelbree Capsules
03 Jun 2025 //
FDA
